MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Software Assists Manufacturers with Product Life-Cycle Management

Article-Software Assists Manufacturers with Product Life-Cycle Management

Originally Published MPMN October 2003

INDUSTRY NEWS

Software Assists Manufacturers with Product Life-Cycle Management

Melody Lee

Product life-cycle management (PLM) software designed specifically for the medical device industry assists companies in managing records in each stage from product R&D to phase-out. AgileMD, produced by Agile Software Corp. (San Jose; www.agile.com) can help medical device companies to manage business issues. Time-to-market problems for new product introduction; product profitability, including cost of documentation; regulatory compliance; and outsourcing are some of the tasks managed by the program. 

"This market depends on its ability to rapidly innovate its product offerings, and at the same time, support rigorous FDA requirements for electronic documentation," says Gisela Wilson, director of PLM solutions for IDC, a global market intelligence and advisory firm. "IDC believes that AgileMD can help medical device and instrumentation manufacturers develop and maintain competitive product portfolios."

The solution is specifically geared toward increasing revenue by accelerating time to market, increasing profits by reducing operating and direct material costs, and ensuring regulatory compliance. With an eye on the entire product life cycle, AgileMD manages the medical device product record through R&D, clinical trials, regulatory approval, new product introduction, market acceptance, and phase-out.

According to the company, customers currently using the solution have increased revenue by improving cycle time up to 60%; increased profits from operating and direct materials cost reductions of 25% and 5%, respectively; and complied with 21 CFR Part 11, prescribing the accepted use of electronic records and signatures.

Copyright ©2003 Medical Product Manufacturing News

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish